BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30645608)

  • 21. The expression of growth differentiation factor 15 in gallbladder carcinoma.
    Yan Y; Yue X; Yang S; Zhao Z; Wu P; Liu H
    J BUON; 2021; 26(1):218-228. PubMed ID: 33721455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GDF-15: a novel serum marker for metastases in uveal melanoma patients.
    Suesskind D; Schatz A; Schnichels S; Coupland SE; Lake SL; Wissinger B; Bartz-Schmidt KU; Henke-Fahle S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):887-95. PubMed ID: 21881845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer.
    Pinar Cilesiz Goksedef B; Gorgen H; Baran SY; Api M; Cetin A
    J Obstet Gynaecol Can; 2011 Aug; 33(8):844-850. PubMed ID: 21846440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
    Zhang AM; Zhang P
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer.
    Ytre-Hauge S; Dybvik JA; Lundervold A; Salvesen ØO; Krakstad C; Fasmer KE; Werner HM; Ganeshan B; Høivik E; Bjørge L; Trovik J; Haldorsen IS
    J Magn Reson Imaging; 2018 Dec; 48(6):1637-1647. PubMed ID: 30102441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
    Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
    Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
    Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS
    Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
    Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
    Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
    Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
    Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer.
    Staff AC; Bock AJ; Becker C; Kempf T; Wollert KC; Davidson B
    Gynecol Oncol; 2010 Sep; 118(3):237-43. PubMed ID: 20576287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between serum growth differentiation factor-15 and 3-month depression after acute ischemic stroke.
    Lu X; Duan J; Cheng Q; Lu J
    J Affect Disord; 2020 Jan; 260():695-702. PubMed ID: 31561112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect.
    Shen Y; Zhang ZB; Wu SD; Wu XB; Li J
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3749-3754. PubMed ID: 29949149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Oemrawsingh RM; Baggen VJ; Kardys I; Cuypers JA; Witsenburg M; van Schaik RH; Roos-Hesselink JW; Boersma E
    Int J Cardiol; 2016 Jan; 202():246-51. PubMed ID: 26402453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity.
    Lee ES; Kim SH; Kim HJ; Kim KH; Lee BS; Ku BJ
    Gut Liver; 2017 Mar; 11(2):276-282. PubMed ID: 27728964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
    Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
    Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.
    Traeger L; Ellermann I; Wiethoff H; Ihbe J; Gallitz I; Eveslage M; Moritz R; Herrmann E; Schrader AJ; Steinbicker AU
    BMC Cancer; 2019 Jan; 19(1):74. PubMed ID: 30646851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the Correlation between Growth Differentiation Factor 15 Serum Level and Its Gene Expression with Psoriasis and Its Severity.
    Akbari H; Talaee R; Zaker SF; Nikoueinejad H
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):593-599. PubMed ID: 34664818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma growth differentiation factor 15 predicts first-ever stroke in hypertensive patients.
    Wang X; Zhu L; Wu Y; Sun K; Su M; Yu L; Chen J; Li W; Yang J; Yuan Z; Hui R
    Medicine (Baltimore); 2016 Jul; 95(30):e4342. PubMed ID: 27472718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.